Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Telix Pharmaceuticals Lim...

    NASDAQ: TLX · Real-Time Price · USD
    16.63
    0.54 (3.36%)
    At close: Jun 16, 2025, 3:59 PM
    16.40
    -1.35%
    After-hours: Jun 16, 2025, 04:20 PM EDT
    3.36%
    Bid 16.01
    Market Cap 5.62B
    Revenue (ttm) 24.45M
    Net Income (ttm) -1.98M
    EPS (ttm) 0.09
    PE Ratio (ttm) 184.72
    Forward PE n/a
    Analyst Strong Buy
    Ask 17.1
    Volume 11,339
    Avg. Volume (20D) 24,047
    Open 16.79
    Previous Close 16.09
    Day's Range 16.10 - 17.02
    52-Week Range 13.61 - 30.36
    Beta 2.41

    About TLX

    undefined

    [Read more]
    Industry n/a
    Sector n/a
    IPO Date n/a
    Employees NaN
    Stock Exchange n/a
    Ticker Symbol TLX
    Website n/a
    Full Company Profile

    Analyst Forecast

    According to 0 analyst ratings, the average rating for TLX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

    Stock Forecasts

    Why Price Moved

    Why Price Moved is a one-sentence explanation of why a stock is moving higher or down. By removing noise and collecting signals from news, press releases and SEC filings, we can pinpoint the trigger for price movements.
    3 months ago
    +12%
    Telix Pharmaceuticals shares are trading higher af... Unlock content with Pro Subscription
    4 months ago
    +1.07%
    Telix Pharmaceuticals shares are trading higher after the company announced it will buy the therapeutic pipeline, technology platform, and research facility from ImaginAb.
    news image

    1 month ago · seekingalpha.com

    Telix Pharmeceuticals: Imaging Biomarkers Paving The Way For Theranostics

    Telix Pharmaceuticals excels in radiopharmaceuticals, with strong revenue growth driven by imaging products like Illuccix and promising therapeutic programs in development. TLX's key imaging projects ...

    news image

    1 month ago · accessnewswire.com

    Shareholders that Lost Money on Telix Pharmaceuticals Limited (TLX) Should Contact Levi & Korsinsky About Securities Fraud Investigation - TLX

    NEW YORK, NY / ACCESS Newswire / May 7, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Telix Pharmaceuticals Limited ("Telix Pharmaceuticals Limited") (NASDAQ:TLX...

    news image

    1 month ago · accessnewswire.com

    ATTENTION Telix Pharmaceuticals Limited Investors: You May Have Been Affected by Fraud- Contact Levi & Korsinsky to Discuss Your Rights

    NEW YORK, NY / ACCESS Newswire / May 6, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Telix Pharmaceuticals Limited ("Telix Pharmaceuticals Limited") (NASDAQ:TLX...

    news image

    1 month ago · accessnewswire.com

    Telix Pharmaceuticals Limited INVESTIGATION: Levi & Korsinsky Investigates Potential Securities Fraud by Telix Pharmaceuticals Limited (TLX)

    NEW YORK, NY / ACCESS Newswire / May 5, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Telix Pharmaceuticals Limited ("Telix Pharmaceuticals Limited") (NASDAQ:TLX...

    news image

    1 month ago · accessnewswire.com

    TLX STOCK ALERT: Levi & Korsinsky Notifies Telix Pharmaceuticals Limited Investors of an Ongoing Investigation

    NEW YORK, NY / ACCESS Newswire / May 1, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Telix Pharmaceuticals Limited ("Telix Pharmaceuticals Limited") (NASDAQ:TLX...

    news image

    1 month ago · accessnewswire.com

    TLX ALERT: Levi & Korsinsky Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by Telix Pharmaceuticals Limited

    NEW YORK, NY / ACCESS Newswire / April 30, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Telix Pharmaceuticals Limited ("Telix Pharmaceuticals Limited") (NASDAQ:...

    news image

    1 month ago · accessnewswire.com

    Levi & Korsinsky Announces an Investigation on Behalf of Telix Pharmaceuticals Limited (TLX) Shareholders Who May Have Been Affected by Fraud

    NEW YORK, NY / ACCESS Newswire / April 28, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Telix Pharmaceuticals Limited ("Telix Pharmaceuticals Limited") (NASDAQ:...

    news image

    2 months ago · zacks.com

    All You Need to Know About Telix Pharmaceuticals Limited (TLX) Rating Upgrade to Buy

    Telix Pharmaceuticals Limited (TLX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

    news image

    2 months ago · zacks.com

    Telix Shares May Gain on the Distribution Deal With Cardinal Health

    TLX rolls out a new e-commerce platform connecting users to top retail pharmacies, aiming to boost savings, improve access, and expand its digital health services.

    news image

    2 months ago · seekingalpha.com

    Telix Pharmaceuticals: Building A Radiopharma Powerhouse

    Telix Pharmaceuticals is leveraging its success with Illuccix to build a diversified theranostic platform, driving long-term value through strategic investments and regulatory wins. Strong financial p...

    Add to Watchlist